1Gupta S. Chronic infection in the aetiology of arteriosclerosis-focus on Chlamydia pneumoniae [ J] . Arteriosclerosis, 1999,143 ( 1 ) : 1-6.
2Moazed TC.Kuo CC, Grayston JT, et al. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse [ J]. J Infect Dis, 1998,177(5 ) : 1322-1325.
3Blessing E, Lin TM, Campbell LA et al. Chlamydia pneumoniae induees inflammatory changes in the heart and aorta of Nonnoeholestrelemic C57 BL/6J Mice [ J ]. Infect Immun, 2000,68 ( 8 ) : 4765 -4768.
4Husain S, Andrews NP, Mulcahy D, et al. Aspirin improves endothelial dysfunction in atherosclerosis[ J]. Circulation, 1998,97(7):716-720.
5Liuba P, Karnani P, Pesonen E, et al. Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice[ J]. Circulation ,2000,102(9) :1039-1044.
6Mozzed TC,Kuo CC Gravston JT, et al. Murine models of Chlamydia pneumoniae infection and atherosclerosis[ J]. J Infect Dis, 1997, 175(4) :883-890.
7Moazed TC, Campbell LA, Rosenfeld ME, et al. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in Apolipoprotein E-Deficient Mice[ J] .J Infect Dis, 1999,180( 1 ) :238-241.
9Hu H,Pierce GN, Zhong G. The atherogenic effects of Chlamydia are dependent on serum cholestrol and specific to Chlamydia pneumoniae[ J].J Clin Invest, 1999,103(5) :747-753.
10Laitinen K, Laufila A, Pyhala L, et al. Chlamydia pneunloniae infection induces inflammatory changes in the aortas of rabbits [J ]. Infect Immun, 1997,65( 11 ) :4832-4835.
